The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
about
Surgical pathology of early stage non-small cell lung carcinomaMolecular Pathology and Personalized Medicine: The Dawn of a New Era in Companion Diagnostics-Practical Considerations about Companion Diagnostics for Non-Small-Cell-Lung-CancerClinical impacts of a micropapillary pattern in lung adenocarcinoma: a reviewFrom tissue to molecular phenotyping: pre-analytical requirements heidelberg experienceThe new 2011 international association for the study of lung cancer/american thoracic society/european respiratory society classification of lung adenocarcinoma in resected specimens: clinicopathologic relevance and emerging issuesAdvances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS)Lung Cancer Gene Signatures and Clinical PerspectivesPrognostic value of microRNA expression in operable non-small cell lung cancer patientsTumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role.Clinical value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma.Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas.Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine.Prognostic factors in resected lung carcinomas.Tumor invasiveness defined by IASLC/ATS/ERS classification of ground-glass nodules can be predicted by quantitative CT parametersC4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinomaOncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinomaRecent advances and clinical implications of the micropapillary histological subtype in lung adenocarcinomasPrognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I diseaseRisk factors of recurrence for resected T1aN0M0 invasive lung adenocarcinoma: a clinicopathologic study of 177 patientsCorrelation of EGFR expression, gene copy number and clinicopathological status in NSCLC.Implementing the new IASLC/ATS/ERS classification of lung adenocarcinomas: results from international and Chinese cohorts.The new IASLC/ATS/ERS lung adenocarcinoma classification from a clinical perspective: current concepts and future prospects.Prognostic implication of predominant histologic subtypes of lymph node metastases in surgically resected lung adenocarcinomaComparison of clinical features, molecular alterations, and prognosis in morphological subgroups of lung invasive mucinous adenocarcinomaNoninvasive risk stratification of lung adenocarcinoma using quantitative computed tomography.The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should knowPredictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancerGalectin-4, a novel predictor for lymph node metastasis in lung adenocarcinomaSolid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence SurvivalRadiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.The percentage of lepidic growth is an independent prognostic factor in invasive adenocarcinoma of the lung.Tumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinomaUsing frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤ 3 cm: accuracy and interobserver agreement.Prognostic value of the IASLC/ATS/ERS classification and IMP3 expression in lung adenocarcinoma of Chinese casesTumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma.Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.A Histopathological Feature of EGFR-Mutated Lung Adenocarcinomas with Highly Malignant Potential - An Implication of Micropapillary Element.Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification.Variation in the expression levels of predictive chemotherapy biomarkers in histological subtypes of lung adenocarcinoma: an immunohistochemical study of tissue samplesThe prognostic and predictive value of solid subtype in invasive lung adenocarcinoma.
P2860
Q26739713-B9098685-69DD-4498-B3D1-AA89C4E8CE4CQ26771116-C2D27458-9AF7-4197-A610-1FFA1060F79EQ26771950-56C72296-4071-4CE6-9CB1-C2B6E088DC1CQ26864637-9997B4D9-1AAA-463B-8A2C-DB8539E53496Q26864736-F591FDCE-2679-43D9-A56B-55A682BF6A7FQ27009370-7C439B86-BA0F-4894-8316-59FBD424E649Q28387769-0AB044F5-BBD7-4A22-993A-98FE63AE67B2Q28396343-AF194F03-A840-4FE0-B260-D0028EE153CCQ30652903-E7EFE78D-6DAB-4E48-9710-26BA82CD148AQ33633606-37284B89-0988-4031-A61D-97750CF4AC21Q33682954-0814A693-616C-4E10-B15F-4F19D3480A45Q33688542-CB002D17-380E-4855-AB7F-55B00E896C33Q33697964-2628D215-3ABE-4393-89B0-0A6B743D3F02Q33780208-E6579798-E685-4062-90E1-7371AF745A5BQ34031219-F4EE939F-24B6-4D83-827D-4B8C15FE20CDQ34073766-DF059410-B15E-4987-A38E-E12D1C94E391Q34141249-1EBBE016-EB76-47BF-97F5-CC84FC849519Q34181641-BCD48CCD-795F-489D-BB6B-DD0150036236Q34208219-700EBCFD-B32A-4728-96C3-621214FECA51Q34252140-D7F3BF2C-5A36-4A11-8B5C-9F12427D4C21Q34404229-97B8583C-CE86-4BC8-B3CF-163357AA2FEFQ34404266-66D51586-85DB-40E9-98A0-D8667194B87DQ34406294-5E048047-2887-42B9-976C-8582C59A19C3Q34567000-CA4E1688-2BAE-4F32-A87D-8287579711C1Q34623141-8BFEC5B1-6FE4-4774-9BE6-671D45780E19Q34748124-6E67C61D-1D48-48BA-9021-EE2D2BBC8065Q34814550-4029DFA3-2226-4643-BC01-2E87C74B1195Q35067654-4AEBDD1E-B3C7-4C78-9835-3C9D264B5677Q35742165-C656B35A-651E-4D75-9C3E-64D5A34F78BCQ35764518-E4D55FF2-E655-4362-9EF1-AC543E534F91Q35838494-73186C7C-BF53-46A1-A6E8-640938D1D78DQ35940727-F3F3D8CA-A8F5-4AD3-B5FA-5FB0B6791EC6Q35954585-5CAA8664-DC8A-4392-AECB-AD8FEA5CCA54Q35993153-788A9265-A903-48DF-BA96-297B3989AFBBQ36015463-E92D4F03-FC07-4716-A90C-9BFF5E0DA68CQ36162509-C26A0F71-6438-4BDC-9E56-F7D3224B12BFQ36197300-14486797-2797-451C-8348-90F11B11A82CQ36239980-B9BF3082-8D1B-4A4E-9DCA-913C0B30CEE7Q36261427-798D121D-B4A6-40CA-B03B-35F487EA4395Q36294486-49A6BAA7-E294-49E4-BD8B-18D6E31AD1E4
P2860
The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
The novel histologic Internati ...... pendent predictor of survival.
@en
The novel histologic Internati ...... pendent predictor of survival.
@nl
type
label
The novel histologic Internati ...... pendent predictor of survival.
@en
The novel histologic Internati ...... pendent predictor of survival.
@nl
prefLabel
The novel histologic Internati ...... pendent predictor of survival.
@en
The novel histologic Internati ...... pendent predictor of survival.
@nl
P2093
P356
P1476
The novel histologic Internati ...... pendent predictor of survival.
@en
P2093
Albrecht Stenzinger
Arne Warth
Hans Hoffmann
Jan Budczies
Michael Meister
Michael Thomas
Peter Schirmacher
Philipp A Schnabel
Thomas Muley
Wilko Weichert
P304
P356
10.1200/JCO.2011.37.2185
P407
P577
2012-03-05T00:00:00Z